SCHEMBL18050890

SCHEMBL18050890

NC(=O)c1ncn(Cc2ccc(Cl)cc2)c1C(N)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD O00767 2/20 0.56
PKM P14618 2/20 0.50
TSHR P16473 2/20 0.50
GAA P10253 1/20 0.50
ADRA1D P25100 1/20 0.46
MAPK1 P28482 2/20 0.44
CYP11B1 P15538 2/20 0.44
CYP11B2 P19099 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HTT P42858 1/20 0.44
ACP1 P24666 1/20 0.42
KCNH2 Q12809 1/20 0.41
LMNA P02545 2/20 0.41
XBP1 P17861 1/20 0.40
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 1/20 0.39
GALR3 O60755 1/20 0.38
CYP3A4 P08684 1/20 0.38
NR2F2 P24468 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18050873 0.92 SCD (0.50) SCDPKMTSHRGAAADRA1D
SCHEMBL18050874 0.87 SCD (0.49) SCDPKMTSHRGAACYP11B1
SCHEMBL18050897 0.87 PKM (0.49) SCDPKMTSHRGAACYP11B1
SCHEMBL18050896 0.86 PKM (0.46) SCDPKMTSHRGAAADRA1D
SCHEMBL7987743 0.85 SCD (0.50) SCDPKMTSHRGAAADRA1D
SCHEMBL2145728 0.85 SCD (0.50) SCDPKMTSHRGAAADRA1D
SCHEMBL18050886 0.85 KDM4E (0.58) SCDPKMTSHRGAAADRA1D
SCHEMBL12604388 0.84 SCD (0.74) SCDPKMTSHRGAAADRA1D
SCHEMBL18050879 0.83 NPC1 (0.47) SCDPKMTSHRGAACYP11B1
SCHEMBL18050876 0.83 KDM4E (0.51) SCDPKMTSHRGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023235376-A1 PROCESS FOR PREPARING 1-(4-CHLOROBENZYL)-1H-IMIDAZOLE-4,5-DICARBOXAMIDE ZOETIS SERVICES LLC (US) 2023-12-07 WO claimed
WO-2023235376-A1 PROCESS FOR PREPARING 1-(4-CHLOROBENZYL)-1H-IMIDAZOLE-4,5-DICARBOXAMIDE ZOETIS SERVICES LLC (US) 2023-12-07 WO disclosed
WO-2023235376-A1 PROCESS FOR PREPARING 1-(4-CHLOROBENZYL)-1H-IMIDAZOLE-4,5-DICARBOXAMIDE ZOETIS SERVICES LLC (US) 2023-12-07 WO disclosed
WO-2023235376-A1 PROCESS FOR PREPARING 1-(4-CHLOROBENZYL)-1H-IMIDAZOLE-4,5-DICARBOXAMIDE ZOETIS SERVICES LLC (US) 2023-12-07 WO disclosed
CN-106692138-B Application of N-benzyl imidazole amide derivative as polymyxin antibiotic synergist 广州英赛特生物技术有限公司 2020-08-04 CN disclosed
US-10435376-B2 Derivatives of 1H-imidazole-4,5-dicarboxamide and use thereof in preparation of anticoccidial drugs Guangzhou Insighter Biotechnology Co., Ltd. (CN) 2019-10-08 US disclosed
US-10435376-B2 Derivatives of 1H-imidazole-4,5-dicarboxamide and use thereof in preparation of anticoccidial drugs Guangzhou Insighter Biotechnology Co., Ltd. (CN) 2019-10-08 US disclosed
US-20180370921-A1 Derivatives of 1H-imidazole-4,5-dicarboxamide and Use Thereof in Preparation of Anticoccidial Drugs GUANGZHOU INSIGHTER BIOTECHNOLOGY CO.,LTD. (CN) 2018-12-27 US disclosed
WO-2017113525-A1 APPLICATION OF N-BENZYLIMIDAZOLECARBOXAMIDE DERIVATIVES AS SYNERGIST FOR POLYMYXIN ANTIBIOTICS 广州英赛特生物技术有限公司 2017-07-06 WO disclosed
CN-106692138-A Application of N-benzylimidamide derivative as polymyxin antibiotic synergist 广州英赛特生物技术有限公司 2017-05-24 CN disclosed
CN-104672145-B Glycalpyramide derivative and application thereof in preparing anticoccidial drug 广州英赛特生物技术有限公司 2017-04-12 CN disclosed
WO-2016141736-A1 GLYCALPYRAMIDE DERIVATIVE AND APPLICATION THEREOF IN PREPARATION OF ANTICOCCIDIAL DRUG 广州英赛特生物技术有限公司 2016-09-15 WO disclosed
WO-2016141736-A1 GLYCALPYRAMIDE DERIVATIVE AND APPLICATION THEREOF IN PREPARATION OF ANTICOCCIDIAL DRUG 广州英赛特生物技术有限公司 2016-09-15 WO disclosed
CN-104672145-A Glycalpyramide derivative and application thereof in preparing anticoccidial drug GUANGZHOU INSIGHTER BIOTECHNOLOGY CO LTD 2015-06-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180370921-A1 Derivatives of 1H-imidazole-4,5-dicarboxamide and Use Thereof in Preparation of Anticoccidial Drugs CYP3A5, DDC, CPS1 SCD 3208/4885PKM 938/4885TSHR 4340/4885
US-10435376-B2 Derivatives of 1H-imidazole-4,5-dicarboxamide and use thereof in preparation of anticoccidial drugs CYP3A5, DDC, CPS1 SCD 3208/4885PKM 938/4885TSHR 4340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.